Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Bottom Line: Regarding adverse effects, 24 patients (46%) had acute Grade 3-4 leukopenia and 5 (10%) had late Grade 3 gastrointestinal toxicities.No patient experienced renal toxicity.Histologic type, maximum tumor diameter, and pretreatment hemoglobin level were statistically significant prognostic factors for PFS.
Affiliation: Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 5650871, Japan email@example.com.Show MeSH
Related in: MedlinePlus
Mentions: Three months after completion of CCRT, 44 patients (85%) achieved CR within the pelvic lesion and 8 (15%) exhibited a partial response (PR). CR of the primary tumor was achieved by 46 patients (88%), but nine developed local recurrence. Of the 52 patients, 20 experienced treatment failure: 15 (29%) had locoregional failure, and 5 (10%) experienced only distant metastases. The estimated 5-year OS, PFS and LC rates were 78% [95% confidence interval (CI), 69–91%], 57% (95% CI, 42–70%) and 73% (95% CI, 58–84%), respectively (Fig. 1).Fig. 1.
Affiliation: Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 5650871, Japan firstname.lastname@example.org.